--- schema_version: "secwatch.filing_event.v1" accession: "0000012208-23-000041" form_type: "8-K" ticker: "BIO" cik: "0000012208" company_name: "BIO-RAD LABORATORIES, INC." filed_at: "2023-05-01T23:59:59+00:00" generated_at: "2026-06-16T04:41:48.571509+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.25 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # Bio-Rad annual meeting results: directors elected, say-on-pay approved, political disclosure rejected ## Summary - All 7 director nominees elected; Melinda Litherland and Arnold Pinkston (Class A) each >73% of votes cast. - KPMG ratified as auditor for FY2023 with 7.26M votes for, 19.7K against. - Non-binding advisory vote on executive compensation approved (6.77M for, 277K against). - Advisory frequency set at three years (5.46M votes for three years vs 1.58M for one year). - Stockholder proposal on political disclosure defeated: 5.94M against, 1.10M for. ## SEC filing metadata - accession: 0000012208-23-000041 - form_type: 8-K - ticker: BIO - cik: 0000012208 - company_name: BIO-RAD LABORATORIES, INC. - filed_at: 2023-05-01T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.25 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/bio-20230425.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0000012208-23-000041 - JSON: https://secwatch.observer/filing/0000012208-23-000041.json - Plain text: https://secwatch.observer/filing/0000012208-23-000041.txt ## Key facts - Shareholder Votes BIO-RAD LABORATORIES, INC. shareholders approved Non-binding advisory vote on the frequency of future advisory votes to approve executive compensation at the 2023-04-25 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2023-04-25 source text: 4 With respect to the non-binding advisory vote on the frequency of future advisory votes to approve executive compensation, Three Years received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Votes Broker 1 Year 2 Years 3 Years Abstaining Non-Votes 1,575,550 14,432 5,461,754 989 225,785 evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm - Shareholder Votes BIO-RAD LABORATORIES, INC. shareholders rejected Stockholder proposal regarding political disclosure at the 2023-04-25 meeting. - Outcome: failed - Meeting: 2023-04-25 source text: 5. The stockholder proposal regarding political disclosure was not approved since the proposal did not receive the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 1,100,154 5,935,081 17,489 225,785 evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm - Shareholder Votes BIO-RAD LABORATORIES, INC. shareholders approved Election of Directors at the 2023-04-25 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-04-25 source text: 1. Each of the nominated directors was elected and received the affirmative vote of a majority of the votes cast in the respective class of Common Stock, as follows: Class of Common Stock Votes Votes Votes Broker to Elect For Against Abstaining Non-Votes Melinda Litherland Class A 14,950,990 5,818,104 4,785 1,695,304 Arnold A. Pinkston Class A 15,729,846 5,037,217 6,816 1,695,304 Jeffrey L. Edwards Class B 4,974,972 275 90 56,255 Gregory K. Hinckley Class B 4,974,972 275 90 56,255 Allison Schwartz Class B 4,972,669 2,578 90 56,255 Norman Schwartz Class B 4,972,669 2,578 90 56,255 evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm - Shareholder Votes BIO-RAD LABORATORIES, INC. shareholders approved Ratification of selection of KPMG LLP as independent auditors at the 2023-04-25 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-04-25 source text: 2. The proposal to ratify the selection of KPMG LLP as the Company’s independent auditors for the fiscal year ending December 31, 2023 was ratified and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 7,258,298 19,666 547 - evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm - Shareholder Votes BIO-RAD LABORATORIES, INC. shareholders approved Non-binding advisory vote to approve executive compensation at the 2023-04-25 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-04-25 source text: 3. The non-binding advisory vote to approve executive compensation was approved and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 6,772,070 277,497 3,158 225,785 evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.